Clinical Study of CWP232291 in Relapsed or Refractory Myeloma Patients
Clinical trial NCT02426723 · COMPLETED
Trial details
- NCT number
- NCT02426723
- Sponsor
- JW Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-19
- Primary completion
- 2018-10-08
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.